2'-cyano-2'-deoxyarabinofuranosylcytosine has been researched along with temozolomide in 1 studies
| Studies (2'-cyano-2'-deoxyarabinofuranosylcytosine) | Trials (2'-cyano-2'-deoxyarabinofuranosylcytosine) | Recent Studies (post-2010) (2'-cyano-2'-deoxyarabinofuranosylcytosine) | Studies (temozolomide) | Trials (temozolomide) | Recent Studies (post-2010) (temozolomide) |
|---|---|---|---|---|---|
| 31 | 0 | 6 | 6,014 | 826 | 4,331 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hargis, S; Jiang, Y; Liu, X; Nowak, B; Plunkett, W | 1 |
1 other study(ies) available for 2'-cyano-2'-deoxyarabinofuranosylcytosine and temozolomide
| Article | Year |
|---|---|
Mechanism-Based Drug Combinations with the DNA Strand-Breaking Nucleoside Analog CNDAC.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cricetinae; Cytarabine; Dacarbazine; DNA Breaks; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Homologous Recombination; Humans; Platinum; Poly (ADP-Ribose) Polymerase-1; Temozolomide; Tumor Suppressor Protein p53 | 2016 |